Bruker Corp (BRKR)

Bruker Stock Analysis & Ratings

Bruker Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Bruker stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


BRKR Stock Stats

Previous Close$68.43
Bid65.18 x 100
Ask69.12 x 100
Today’s Range$67.1 - $69.75
52-Week Range$54.46 - $92.35
Average Volume952.06K
Market Cap$10.19B
P/E Ratio38.1
Earnings DateFeb 14, 2022
Dividend & Yield0.16 (0.23%)
Ex-Dividend DateNov 30, 2021

Company Description

Bruker Corp

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.
Medical Devices & Instruments
Frank H. Laukien
40 Manning Road, Billerica, MA, 01821, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Bruker’s price range in the past 12 months?
Bruker lowest stock price was $54.46 and its highest was $92.35 in the past 12 months.
    What is Bruker’s market cap?
    Bruker’s market cap is $10.19B.
      What is Bruker’s price target?
      The average price target for Bruker is $92.67. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $98.00 ,the lowest forecast is $90.00. The average price target represents 37.88% Increase from the current price of $67.21.
        What do analysts say about Bruker?
        Bruker’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is Bruker’s upcoming earnings report date?
          Bruker’s upcoming earnings report date is Feb 14, 2022 which is in 24 days.
            How were Bruker’s earnings last quarter?
            Bruker released its earnings results on Nov 02, 2021. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.442 by $0.188.
              Is Bruker overvalued?
              According to Wall Street analysts Bruker’s price is currently Undervalued.
                Does Bruker pay dividends?
                Bruker pays a Quarterly dividend of $0.04 which represents an annual dividend yield of 0.23%. Bruker’s last Quarterly dividend payment was on Dec 17, 2021. Bruker’s upcoming ex-dividend date is Nov 30, 2021
                  What is Bruker’s EPS estimate?
                  Bruker’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Bruker have?
                  Bruker has 151,660,000 shares outstanding.
                    What happened to Bruker’s price movement after its last earnings report?
                    Bruker reported an EPS of $0.63 in its last earnings report, beating expectations of $0.442. Following the earnings report the stock price went down -0.37%.
                      Which hedge fund is a major shareholder of Bruker?
                      Among the largest hedge funds holding Bruker’s share is Sivik Global Healthcare LLC. It holds Bruker’s shares valued at 6M.

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis